TRCT
ALHC icon

Tower Research Capital (TRC)’s Alignment Healthcare ALHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
17,616
+7,298
+71% +$147K 0.01% 1284
2025
Q4 		$204K Buy
10,318
+4,512
+78% +$81.1K ﹤0.01% 1423
2025
Q3 		$101K Sell
5,806
-13,873
-70% -$206K ﹤0.01% 1981
2025
Q2 		$276K Buy
19,679
+18,784
+2,099% +$302K 0.01% 1500
2025
Q1 		$16.7K Sell
895
-9,676
-92% -$144K ﹤0.01% 3149
2024
Q4 		$119K Buy
10,571
+6,286
+147% +$73.5K ﹤0.01% 2060
2024
Q3 		$50.6K Sell
4,285
-6,239
-59% -$59K ﹤0.01% 2715
2024
Q2 		$82.3K Buy
10,524
+10,040
+2,074% +$65.5K ﹤0.01% 2723
2024
Q1 		$2.4K Sell
484
-18,616
-97% -$119K ﹤0.01% 5045
2023
Q4 		$164K Buy
19,100
+14,821
+346% +$108K ﹤0.01% 2255
2023
Q3 		$29.7K Sell
4,279
-3,304
-44% -$19.9K ﹤0.01% 3035
2023
Q2 		$43.6K Buy
7,583
+4,652
+159% +$30.1K ﹤0.01% 2690
2023
Q1 		$19K Buy
2,931
+2,089
+248% +$19.9K ﹤0.01% 3465
2022
Q4 		$10K Sell
842
-16,926
-95% -$206K ﹤0.01% 3943
2022
Q3 		$210K Buy
17,768
+14,808
+500% +$216K ﹤0.01% 1882
2022
Q2 		$34K Buy
2,960
+1,784
+152% +$18.8K ﹤0.01% 3236
2022
Q1 		$13K Sell
1,176
-5,315
-82% -$47.8K ﹤0.01% 3952
2021
Q4 		$91K Buy
6,491
+2,306
+55% +$40.4K ﹤0.01% 2286
2021
Q3 		$67K Buy
4,185
+3,864
+1,204% +$74.6K ﹤0.01% 2720
2021
Q2 		$8K Sell
321
-40
-11% -$973 ﹤0.01% 4474
2021
Q1 		$8K Buy
+361
New +$7.06K ﹤0.01% 4458

Other funds holding ALHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tower Research Capital (TRC)'s ALHC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Alignment Healthcare (ALHC) stake by 71% in Q1 2026, buying an estimated $147K and bringing the position to 17,616 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #1284.

Tower Research Capital (TRC) first reported a position in ALHC in Q1 2021 and has held it in 21 quarters since. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Tower Research Capital (TRC) held 17,616 shares of Alignment Healthcare worth $310K as of Q1 2026.
  • Tower Research Capital (TRC) bought 7,298 Alignment Healthcare shares in Q1 2026, an estimated $147K.
  • Alignment Healthcare made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1284 holding.
  • Tower Research Capital (TRC) first reported a position in Alignment Healthcare in Q1 2021 and has held it in 21 quarters since.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.